Willis Investment Counsel Biogen Inc. Transaction History

Willis Investment Counsel

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $193,770 - $244,140	-1,000 Closed	0 $0
Q3 2021 Nov 17, 2021	SELL	$282.99 - $369.05 $2,829 - $3,690	-10 Reduced 0.99%	1,000 $283,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $2,590 - $4,147	10 Added 1.0%	1,010 $350,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $242,950 - $284,630	1,000 New	1,000 $280,000

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Willis Investment Counsel with notifications on news.